Novartis stock after-hours at EUR 124.59: minus 0.61 percent versus prior close
Published on 10/05/2026 at 19:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novartis stock was at EUR 124.59 after-hours at 7:17 p.m. CEST on October 5, 2026, a change of minus 0.61 percent versus the prior close of EUR 125.36 at Lang & Schwarz.
Novartis stock in after-hours trading
The Lang & Schwarz price was EUR 124.59 at 7:17 p.m. CEST, compared with the previous close of EUR 125.36. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Novartis stock.
Abogen agreement covers mRNA therapy
On October 2, 2026, Abogen Biosciences announced a licensing and option agreement with Novartis covering an exclusive worldwide license to ABO2203, an mRNA-encoded CD19xCD3 T-cell engager, and options for additional programs using Abogen’s RNA platform, according to PR Newswire.
Under the proposed agreement, Abogen is due an upfront payment of USD 575 million and could receive up to approximately USD 7.2 billion in milestone payments if all options are exercised. The payments depend on development, regulatory and commercial milestones, and the transaction remains subject to customary closing conditions, including required regulatory clearances, Reuters reported.
